Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to $121.2 million.

  • Lifecore Biomedical, Inc. \De\'s Non-Current Debt rose 2021.35% to $121.2 million in Q2 2025 from the same period last year, while for May 2025 it was $121.2 million, marking a year-over-year increase of 2021.35%. This contributed to the annual value of $121.2 million for FY2025, which is 2021.35% up from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Non-Current Debt is $121.2 million, which was up 2021.35% from $115.7 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Non-Current Debt high stood at $164.9 million for Q2 2021, and its period low was $79.6 million during Q1 2022.
  • Moreover, its 5-year median value for Non-Current Debt was $105.5 million (2024), whereas its average is $110.1 million.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Non-Current Debt soared by 6268.46% in 2021, and later plummeted by 4512.41% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Non-Current Debt (Quarter) stood at $124.2 million in 2021, then tumbled by 35.91% to $79.6 million in 2022, then grew by 15.69% to $92.1 million in 2023, then increased by 20.03% to $110.5 million in 2024, then rose by 9.65% to $121.2 million in 2025.
  • Its Non-Current Debt was $121.2 million in Q2 2025, compared to $115.7 million in Q1 2025 and $110.5 million in Q4 2024.